* Cardio Diagnostics Holdings Inc is expected to show a rise in quarterly revenue when it reports results on March 31 (estimated) for the period ending December 31 2023
* The Chicago Illinois-based company is expected to report a 26,215.8% increase in revenue to $250 thousand from $9.5 hundred a year ago, according to the estimate from one analyst, based on LSEG data.
* LSEG's mean analyst estimate for Cardio Diagnostics Holdings Inc is for a loss of 13 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Cardio Diagnostics Holdings Inc is $6.00, above its last closing price of $1.42.
This summary was machine generated March 29 at 20:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments